Baillie Gifford & CO Amneal Pharmaceuticals, Inc. Transaction History

Baillie Gifford & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$3.01 - $4.46 $2,567 - $3,804	-853 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$3.9 - $4.89 $1,563 - $1,960	401 Added 88.72%	853 $4,000
Q1 2021 May 06, 2021	SELL	$4.74 - $7.38 $308 - $479	-65 Reduced 12.57%	452 $3,000
Q4 2020 Feb 10, 2021	BUY	$3.95 - $5.42 $2,042 - $2,802	517 New	517 $2,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.